GBIO NASDAQ
Generation Bio Co.
1W: +3.8%
1M: +12.5%
3M: -5.8%
1Y: -46.9%
3Y: -86.5%
5Y: -98.4%
$5.34
Last traded 2025-12-31 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$36.0M
52W Range3.004-7.516
Volume551,924
Avg Volume82,006
Beta2.01
Dividend—
Analyst Ratings
Company Info
CEOYalonda Howze
Employees115
SectorHealthcare
IndustryBiotechnology
IPO Date2020-06-12
Websitegenerationbio.com
301 Binney Street
Cambridge, MA 02142
US
Cambridge, MA 02142
US
617 655 7500
About Generation Bio Co.
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Latest News
Generation Bio Co. (NASDAQ:GBIO) Receives Average Recommendation of “Hold” from Brokerages
Brokerages Set Generation Bio Co. (NASDAQ:GBIO) PT at $9.25
Shareholder Alert: The Ademi Firm investigates whether Generation Bio Co. is obtaining a Fair Price for its Public Shareholders
GBIO Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Generation Bio Co. is Fair to Shareholders
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Atlas Venture Fund X | U-Tender | 60 | $0.00 | 2026-02-09 |
| Stehman-Breen Cather | D-Return | 6,000 | $33.20 | 2026-02-09 |
| Stehman-Breen Cather | D-Return | 3,000 | $3.87 | 2026-02-09 |
| Stehman-Breen Cather | D-Return | 5,200 | $190.00 | 2026-02-09 |
| Stehman-Breen Cather | D-Return | 1,500 | $265.90 | 2026-02-09 |